Chronic Constipation Clinical Trial
Official title:
Evaluation of Efficacy and Safety of the Combined Seed Extracts of Cassia Obtusifolia Linne and Foeniculum Vulgare Mill in Patients With Chronic Constipation: a Double-blind, Randomized, Placebo-controlled Study
The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects and safety of the combination seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill in patients with chronic constipation for 4 weeks.
A previous animal study has indicated that the combined seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill have a laxative effect by recovering stool parameters, colonic morphology, and activation of mAchRs and their downstream signaling pathway in constipation. Furthermore, this study provides that the combined seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill could be considered as a therapeutic drug candidate for the prevention or treatment of constipation. Therefore, the investigators a randomized, double-blind, placebo-controlled study to investigate the effects and safety of the combination seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill in patients with chronic constipation for 4 weeks. The Investigators examine stool transit time, constipation Visual Analogue Scale (VAS), Bristol stool Form scale type 3 and 4 (frequency per week), VAS for Irritable Bowel Syndrome (VAS-IBS) questionnaire, IBS severity scoring system, BS Quality of Life instrument at baseline, as well as after 2 and 4 weeks of intervention. Interferon-1β and tumor necrosis factor-α concentrations were measured at baseline and 4 weeks. One hundred adults were administered either 1,000 mg of the combined seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill or a placebo each day for 4 weeks. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980988 -
Effectiveness and Safety of Probiotic in Regulating Chronic Constipation
|
N/A | |
Recruiting |
NCT03819062 -
Sacral Neuromodulation as Treatment for Chronic Constipation
|
N/A | |
Completed |
NCT00765882 -
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
|
Phase 3 | |
Completed |
NCT00730171 -
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT00354575 -
Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care Units
|
Phase 2 | |
Active, not recruiting |
NCT03119584 -
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
|
Phase 4 | |
Completed |
NCT00765999 -
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
Completed |
NCT01793753 -
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
|
N/A | |
Completed |
NCT00746200 -
Acupuncture for Chronic Constipation
|
Phase 3 | |
Enrolling by invitation |
NCT00671684 -
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00391820 -
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
|
Phase 2 | |
Completed |
NCT00404040 -
Movicol in Childhood Constipation (ProMotion Study)
|
Phase 2 | |
Completed |
NCT02281630 -
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
|
Phase 2 | |
Completed |
NCT00256984 -
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
Phase 4 | |
Recruiting |
NCT05192317 -
Administration of a Natural Molecular Complex in Functional Chronic Constipation
|
N/A | |
Active, not recruiting |
NCT05202028 -
The Efficacy of Massage and Reflexology Applications in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT05734859 -
Drinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation
|
N/A | |
Completed |
NCT01007123 -
Study of A3309 in Patients With Chronic Idiopathic Constipation
|
Phase 2 | |
Completed |
NCT00402337 -
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
|
Phase 2 | |
Completed |
NCT02961556 -
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
|
Phase 3 |